Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

The United States Cutaneous Lymphoma Consortium is a multidisciplinary society of physicians which use collaborative research and education to improve the quality of life and prognosis of patients ...

A new study showed that psoriasis patients were 1.68 times more likely to acquire onychomycosis than people without psoriasis ...

SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Presentation Highlights HyBryte Potential in CTCL In January 2025, Dr ...

Onychomycosis Treatment MarketThe global onychomycosis treatment market is projected to grow from USD 4,738.3 million in 2023 to USD 10,608.8 million by 2033, exhibiting a robust CAGR of 8.4% during ...

CTCL accounts for approximately 4% of all non-Hodgkin’s lymphomas and has a median age at diagnosis of 55-65 years. Mycosis fungoides, and Sézary syndrome, its leukemic variant, are the most common ...

A psychological horror story set in rural Wales amid the mysterious world of mycelium. A psychological horror story set in rural Wales amid the mysterious world of mycelium. A psychological horror ...

It can lead to rash-like redness, scaly patches or plaques, and tumors. The most common type of cutaneous T-cell lymphoma is called mycosis fungoides. A less common form, Sezary syndrome, can lead to ...

Symptom control is often the goal for patients who have mycosis fungoides, the most common type of cutaneous T-cell lymphoma. Mycosis fungoides tends to advance slowly, so symptom control can help you ...